EMA receives application for conditional marketing authorisation of Moderna COVID-19 vaccine
- Details
- Category: EMA

FDA authorizes monoclonal antibodies for treatment of COVID-19
- Details
- Category: FDA

FDA approves first treatment for COVID-19
- Details
- Category: FDA

EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation
- Details
- Category: EMA

FDA issues emergency use authorization for convalescent plasma as potential promising COVID-19 treatment
- Details
- Category: FDA

FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines
- Details
- Category: FDA

FDA announces first of its kind pilot program to communicate patient reported outcomes from cancer clinical trials
- Details
- Category: FDA

More Pharma News ...
- FDA revokes emergency use authorization for chloroquine and hydroxychloroquine
- Global regulators commit to cooperate on observational research in the context of COVID-19
- FDA takes new actions to accelerate development of novel prevention, treatment options for COVID-19
- FDA Issues Emergency Use Authorization for Potential COVID-19 Treatment
- FDA reiterates importance of close patient supervision for 'off-label' use of antimalarial drugs
- FDA encourages recovered patients to donate plasma for development of blood-related therapies
- FDA Coordinates National Effort to Develop Blood-Related Therapies for COVID-19